Safety of Prednisone for Ocular Myasthenia Gravis

Update Item Information
Identifier 20120214_nanos_posters_089
Title Safety of Prednisone for Ocular Myasthenia Gravis
Creator Beau Bruce, MD, PhD, Emory University; Mark J. Kupersmith, MD, Mount Sinai
Subject ocular myasthenia gravis; prednisone; clinical trials; safety
Description Treatment with chronic corticosteroids has been associated with frequent significant adverse effects. We hypothesized that the major side effect profile of a long-term, low-dose prednisone regimen for OMG was low.
Date 2012-02-14
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2012 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2012: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2012. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s60g6rq4
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 181995
Reference URL https://collections.lib.utah.edu/ark:/87278/s60g6rq4
Back to Search Results